Christopher A. Kuebler

Former Chief Executive Officer at Covance, Inc.

Christopher A. Kuebler

Christopher A. Kuebler

Former Chief Executive Officer at Covance, Inc.

Overview
Career Highlights

Covance, Inc.

RelSci Relationships

820

Number of Boards

4

Birthday

1952

Age

67

Relationships
RelSci Relationships are individuals Christopher A. Kuebler likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman, President & Chief Executive Officer at Waters Corp.

Relationship likelihood: Strong

Former Chief Executive Officer at Reliant Pharmaceuticals LLC

Relationship likelihood: Strong

President & Chief Executive Officer at Nektar Therapeutics

Relationship likelihood: Strong

Former Chief Financial Officer at Covance, Inc.

Relationship likelihood: Strong

Director at Reform Biologics LLC

Relationship likelihood: Strong

Co-Chairman at Bain Capital LP

Relationship likelihood: Strong

Former Independent Investor & Life Sciences Consultant at MJB Consulting

Relationship likelihood: Strong

President & Chief Executive Officer at Dana-Farber Cancer Institute, Inc.

Relationship likelihood: Strong

Independent Consultant at NVIDIA Corp.

Relationship likelihood: Strong

Co-Founder at SFW Capital Partners LP

Relationship likelihood: Strong

Paths to Christopher A. Kuebler
Potential Connections via
Relationship Science
You
Christopher A. Kuebler
Former Chief Executive Officer at Covance, Inc.
Education
BS in Biological Science

The Florida State University (commonly referred to as Florida State or FSU)[9] is a space-grant and sea-grant public research university located in the state capital city of Tallahassee, Florida, United States. It is a comprehensive doctoral research university with medical programs and very high research activity as determined by the Carnegie Foundation.[10] The university comprises 16 separate colleges and more than 110 centers, facilities, labs and institutes that offer more than 300 programs of study, including professional programs.[11] Florida State is home to Florida's only National Laboratory – the National High Magnetic Field Laboratory and is the birthplace of the commercially viable anti-cancer drug Taxol. Florida State University also operates The John & Mable Ringling Museum of Art, the State Art Museum of Florida and one of the largest museum/university complexes in the nation.[12] Florida State University is accredited by the Southern Association of Colleges and Schools as a Level VI public institution.[13] Florida State was officially established in 1851 and is located on the oldest continuous site of higher education in the state of Florida.[2][3] In 1905 Florida State earned Florida's first Rhodes Scholar.[14][15] In 1935 Florida State University was awarded the first chapter of Phi Beta Kappa in Florida and is among the ten percent of American universities to have earned a chapter of the national academic honor society.[16][17] In 1977 Florida State University earned the first female Rhodes Scholar in Florida.[18] In 2007, the Florida Legislature permitted Florida State and the University of Florida to charge 40% higher tuition than other institutions in the State University System of Florida.[19] In 2010 Florida State University was named a "Budget Ivy" university by the Fiske Guide to Getting into the Right College.[20] In 2012 U.S. News & World Report ranked Florida State the most efficient National University in the United States.[21] Florida State University is one of two Florida public universities to immediately qualify as a "preeminent university" by law under Florida Senate Bill 1076, signed by Governor Rick Scott in 2013.[22][23] As a result of this legislation, preeminent universities receive additional funding that is intended to improve the academics and national reputation of higher education within the state of Florida.[24] As one of Florida's primary graduate research universities,[25] Florida State University awards approximately 3,000 graduate and professional degrees each year.[26] The Florida State University is also home to nationally ranked programs in many academic areas, including the sciences, engineering, social policy, film, music, theater, dance, visual art, business, political science, psychology, social work, medicine, and law.[27] The university is also known for its undergraduate study abroad options: according to Uni in the USA, "the large numbers of students that study abroad nicely compliment the students that study here from abroad."[28] Florida State University athletics programs are favorites of passionate students, fans and alumni across the United States, which often appear in conjunction with the Marching Chiefs of the FSU College of Music. Florida State is a member of the Atlantic Coast Conference and has won thirteen national athletic championships as well as multiple individual competitor NCAA championship awards

Career History
Chief Executive Officer
1994 - 2005

Covance, with headquarters in Princeton, New Jersey, is one of the world’s largest and most comprehensive drug development services companies, with annual revenues greater than $2 billion, employees in more than 60 countries, and more than 11,000 employees worldwide.

Vice President, Sales & Marketing of Pharmaceutical Division
1986 - 1994

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Professional
Prior
Boards & Committees
Independent Director
2006 - Current

For fifty years, Waters Corp. has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance. Waters Corp., a publicly traded corporation (NYSE:WAT) headquartered in Milford, Massachusetts, holds worldwide leading positions in complementary analytical technologies - liquid chromatography, mass spectrometry, rheometry and microcalorimetry. These markets account for approximately $5.0 billion of the estimated $20 - $25 billion worldwide analytical instrumentation market. Specifically, the company designs, manufactures, sells and services ultra performance liquid chromatography (UPLC), high performance liquid chromatography (HPLC), chromatography columns and chemistry products, mass spectrometry (MS) systems, thermal analysis and rheometry instruments. Waters Corp. operates in two divisions: Waters Division and TA Instruments

Independent Director
2001 - 2018

Nektar Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients. Its product pipeline consists of drug candidates across a number of therapeutic areas, including oncology, pain, anti-infectives, anti-viral and immunology. Nektar's research and development activities involve small molecule drugs, peptides and other potential biologic drug candidates. Its drug candidates are designed to improve the pharmacokinetics, pharmacodynamics, half-life, bioavailability, metabolism or distribution of drugs and improve the overall benefits and use of a drug for the patient.

Chairman
1994 - 2005

Covance, with headquarters in Princeton, New Jersey, is one of the world’s largest and most comprehensive drug development services companies, with annual revenues greater than $2 billion, employees in more than 60 countries, and more than 11,000 employees worldwide.

Director
Prior

Ocean Conservancy provides wildlife services. The firm protects the ocean from global challenges. It creates science based solutions for a healthy ocean and the wildlife and communities that depend on it. The company was founded in 1972 and is headquartered in Washington, DC.

Political Donations
$500
2006

Former Representative from Florida's 21st Congressional District

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Christopher A. Kuebler. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Christopher A. Kuebler's profile does not indicate a business or promotional relationship of any kind between RelSci and Christopher A. Kuebler.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/christopher-a-kuebler-3221756
  • https://relationshipscience.com/person/christopher-a-kuebler-3221756